Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 77 | SFEBES2021 | Next issue

Society for Endocrinology BES 2021

Edinburgh, United Kingdom
08 Nov 2021 - 10 Nov 2021

Card image cap
Join us in Edinburgh for the flagship event of the Society for Endocrinology

Oral Communications

Bone and Calcium

ea0077oc5.1 | Bone and Calcium | SFEBES2021

Successful adeno-associated virus mediated neonatal gene therapy treatment of hypophosphatasia murine model resulted in bone maturation and increased survival to at least 18 months

Matsumoto Tae , Miyake Noriko , Zhao Dongwei , Narisawa Sonoko , Millan Jose , Miyake Koichi

Hypophosphatasia (HPP) is an inherited skeletal disease characterized by defective bone mineralization due to a deficiency in tissue-nonspecific alkaline phosphatase (TNALP). Patients with the severe infantile form of HPP have a poor prognosis that often results in high mortality by one year. Asfotase alfa is an approved therapy for HPP, while requires chronic injections to maintain efficacy. To develop a one-time gene therapy for HPP, we examined the safety and efficacy of AA...

ea0077oc5.2 | Bone and Calcium | SFEBES2021

Gastric inhibitory polypeptide (GIP) reduces human osteoclast activity by suppressing multiple signalling pathways

Hansen Morten S , Soe Kent , Gorvin Caroline M , Frost Morten

Gastric inhibitory polypeptide (GIP) is a post-prandially secreted gut hormone that acts upon the GIP-receptor (GIPR), to stimulate insulin secretion. Animal studies indicate that GIP influences bone remodelling, and in humans, GIP administration decreases levels of bone resorption markers. However, the mechanisms by which GIP influences resorption remain to be elucidated. Therefore, we investigated how GIP (10nM) affects bone cell activity using primary human osteoclasts, hum...

ea0077oc5.3 | Bone and Calcium | SFEBES2021

Role of Intact and C-Terminal FGF-23 Assays in the Investigation of Metabolic Bone Disease.

Jethwa Kishan , Bhatti Sumbal , Chipchase Allison , Piec Isabelle , Fraser William , Turner Jeremy

Fibroblast growth factor 23 (FGF-23) is a phosphatonin produced by osteocytes in response to serum phosphate concentration. Immunoassays are widely employed to detect C-terminal fragments of FGF-23 (cFGF-23). Quantitative assays for intact FGF-23 (iFGF-23) measurement are also available. Causes of increased FGF-23 include Tumour Induced Osteomalacia (TIO), X-linked hypophosphataemic rickets (XLH) and end stage renal disease (ESRD). We observed that some individuals, with no id...

ea0077oc5.4 | Bone and Calcium | SFEBES2021

Nuclear factor I/X (NFIX) regulates the transcriptional activity of the cellular retinoic acid binding protein 2 (CRABP2) promoter and alters CRABP2 expression in Marshall-Smith Syndrome (MSS) patients.

Kooblall Kreepa , Stevenson Mark , Lines Kate , Stewart Michelle , Wells Sara , Teboul Lydia , Hennekam Raoul , Thakker Rajesh

Marshall-Smith syndrome (MSS) is a congenital disorder affecting skeletal and neural development, due to mutations in the nuclear factor I/X (NFIX) gene. NFIX encodes a ubiquitously expressed transcription factor that regulates the expression of viral and cellular genes. To identify novel genes that are misregulated by NFIX mutations, RNA sequencing and proteomics analyses were performed on mouse embryonic fibroblast (MEF) cells derived from a repres...

ea0077oc5.5 | Bone and Calcium | SFEBES2021

Diacylglycerol kinase delta haploinsufficiency in mice causes hypocalcaemia: relevance to human Autosomal Dominant Hypoclacemia (ADH)

Goldsworthy Michelle , Lovegrove Catherine , Moir Lee , Wiberg Akira , Turney Benjamin , Furniss Dominic , Hannan Fadil , Thakker Rajesh , Howles Sarah

Diacylglycerol kinase delta (DGKD) has been implicated in calcium homeostasis and nephrolithiasis by genome-wide association studies. We have previously demonstrated that alterations in expression of DGKD cause biased calcium-sensing receptor (CaSR) signalling in vitro. To further elucidate the physiological role of DGKD we examined the biochemical phenotype of a Dgkd-haploinsufficient (+/-) mutant mouse developed by the International Mouse Phenotyping Consor...

ea0077oc5.6 | Bone and Calcium | SFEBES2021

The role of vitamin D supplementation in critically ill patients with COVID-19

Hoskyns Samuel , Payne-Doris Thomas , Hardy Gavin , Bain Robert

Background: Studies have established a link between vitamin D deficiency and susceptibility to and severity of COVID-19. Our study aims to evaluate the role of vitamin D supplementation in intensive care units (ICU) in patients with COVID-19.Methods: We conducted a retrospective analysis of patients admitted to ICU in a large tertiary centre. Data on serum vitamin D concentration and supplementation, mortality, hospital and ICU stay, electrolyte replacem...